Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.665 USD | +5.32% | +9.21% | +144.26% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+144.26% | 156M | |
+29.73% | 48.16B | |
-1.05% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.10% | 25.59B | |
-23.03% | 18.96B | |
+8.31% | 12.92B | |
+28.90% | 12.03B | |
-1.92% | 11.77B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- Cardiff Oncology Shares Jump; Company Sets Lead Program in First-Line Metastatic Colorectal Cancer